Wells Fargo & Company Avid Bioservices, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 34,058 shares of CDMO stock, worth $425,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,058
Previous 24,266
40.35%
Holding current value
$425,384
Previous $276,000
52.17%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CDMO
# of Institutions
209Shares Held
67.1MCall Options Held
216KPut Options Held
4.6K-
Black Rock Inc. New York, NY5.11MShares$63.8 Million0.0% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.8MShares$47.4 Million4.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.77MShares$47.1 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY3.72MShares$46.4 Million3.11% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.88MShares$36 Million2.11% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $776M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...